The use of high-dose melatonin in liver resection is safe: First clinical experience

Journal of Pineal Research

Volumn 50, Issue 4, 2011, Pages 381-388

  Nickkholgh, Arash ^a   Schneider, Heinz ^b   Sobirey, Michael ^c   Venetz, Werner P ^d   Hinz, Ulf ^a   Pelzl, Le H ^a   Gotthardt, Daniel N ^a   Cekauskas, Albertas ^a   Manikas, Martynas ^a   Mikalauskas, Saulius ^a   Mikalauskene, Laura ^a   Bruns, Helge ^a   Zorn, Markus ^a   Weigand, Markus A ^a   Büchler, Markus W ^a   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HealthEcon Ltd   (Switzerland)

^c Nutri Fit GmbH and Co KG   (Germany)

^d Datagen AG   (Switzerland)

Author keywords

antioxidant; liver resection; melatonin; warm ischemia

Indexed keywords

AMINOTRANSFERASE; LACTIC ACID; MELATONIN; MICROCRYSTALLINE CELLULOSE; PLACEBO;

ABDOMINAL INFECTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ARGON PLASMA COAGULATION; ARTICLE; ASYSTOLE; ATRIOVENTRICULAR BLOCK; BILE DUCT CARCINOMA; BILE DUCT FISTULA; BODY WEIGHT; BRADYCARDIA; BRAIN CANCER; BRAIN DISEASE; BREAST CANCER; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIRIUM; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; GALLBLADDER CANCER; GENERAL ANESTHESIA; HUMAN; HYPOTENSION; ILEUS; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER RESECTION; MALE; MELANOMA; METABOLIC ACIDOSIS; MILK; NASOPHARYNX CANCER; NASOTRACHEAL INTUBATION; NAUSEA; OPERATION DURATION; PACEMAKER; PANCREAS CANCER; PILOT STUDY; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH TUBE; SURGICAL PATIENT; THORAX PAIN; TREATMENT INDICATION; TREATMENT REFUSAL; URTICARIA; VOMITING; WOUND DEHISCENCE;

AGED; ANTIOXIDANTS; DOUBLE-BLIND METHOD; FEMALE; HEPATECTOMY; HUMANS; MALE; MELATONIN; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 79954419394     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00854.x     Document Type: Article

References (54)

1. Lerner AB, Case JD, Takahashi Y,. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J Biol Chem 1960; 235: 1992-1997.
2. Tan DX, Manchester LC, Terron MP, et al., One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42. (Pubitemid 44924323)
3. Hardeland R, Reiter RJ, Poeggeler B, Tan DX,. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993; 17: 347-357. (Pubitemid 23306320)
4. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
5. Bubenik GA,. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348. (Pubitemid 35205309)
6. Acuña-Castroviejo D, Reiter RJ, Menéndez-Peláez A, et al., Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. J Pineal Res 1994; 16: 100-112.
7. Tan D, Manchester LC, Reiter RJ, et al., High physiological levels of melatonin in the bile of mammals. Life Sci 1999; 65: 2523-2529.
8. Tan DX, Manchester LC, Hardeland R, et al., Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34: 75-78.
9. Liang R, Nickkholgh A, Hoffmann K, et al., Melatonin protects from hepatic reperfusion injury through inhibition of IKK and JNK pathways and modification of cell proliferation. J Pineal Res 2009; 46: 8-14.
10. Chen JC, Ng CJ, Chiu TF, Chen HM,. Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion. J Pineal Res 2003; 34: 260-264.
11. Jimenez MF, Watson RW, Parodo J, et al., Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997; 132: 1263-1269.
12. Schemmer P, Nickkholgh A, Schneider H, et al., PORTAL: pilot study on the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection: a double-blind randomized placebo-controlled trial. BMC Surg 2008; 8: 2.
13. Nickkholgh A, Schneider H, Sobirey M, et al., Melatonin in liver resection: first clinical experience. Transpl Int 2010; 23: 37.
14. Schemmer P, Friess H, Dervenis C, et al., The use of endo-GIA vascular staplers in liver surgery and their potential benefit: a review. Dig Surg 2007; 24: 300-305. (Pubitemid 47174047)
15. Schemmer P, Bruns H, Weitz J, et al., Liver transection using vascular stapler: a review. HPB (Oxford) 2008; 10: 249-252.
16. Schemmer P, Friess H, Hinz U, et al., Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg 2006; 30: 419-430. (Pubitemid 43261368)
17. Levy MM, Fink MP, Marshall JC, et al., SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256. (Pubitemid 36444440)
18. Venkataraman R, Kellum JA,. Defining acute renal failure: the RIFLE criteria. J Intensive Care Med 2007; 22: 187-193. (Pubitemid 47094112)
19. Pringle JH,. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48: 541-549.
20. Clavien PA, Petrowsky H, Deoliveira ML, et al., Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-1559. (Pubitemid 46588419)
21. Rahbari NN, Wente MN, Schemmer P, et al., Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg 2008; 95: 424-432.
22. Schemmer P, Schoonhoven R, Swenberg JA, et al., Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells. Transplantation 1998; 65: 1015-1020. (Pubitemid 28208417)
23. Schemmer P, Connor HD, Arteel GE, et al., Reperfusion injury in livers due to gentle in situ organ manipulation during harvest involves hypoxia and free radicals. J Pharmacol Exp Ther 1999; 290: 235-240. (Pubitemid 29302325)
24. Schemmer P, Bunzendahl H, Klar E, Thurman RG,. Reperfusion injury is dramatically increased by gentle liver manipulation during harvest. Transpl Int 2000; 13: S525-S527.
25. Schemmer P, Enomoto N, Bradford BU, et al., Activated Kupffer cells cause a hypermetabolic state after gentle in situ manipulation of liver in rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: 1076-1082.
26. Schemmer P, Enomoto N, Bradford BU, et al., Autonomic nervous system and gut-derived endotoxin: involvement in activation of Kupffer cells after in situ organ manipulation. World J Surg 2001; 25: 399-406. (Pubitemid 32455188)
27. Schemmer P, Schoonhoven R, Swenberg JA, et al., Gentle organ manipulation during harvest as a key determinant of survival of fatty livers after transplantation in the rat. Transpl Int 1999; 12: 351-359. (Pubitemid 29502005)
28. Schemmer P, Mehrabi A, Kraus T, et al., New aspects on reperfusion injury to liver-impact of organ harvest. Nephrol Dial Transplant 2004; 19: 26-35.
29. Golling M, Jahnke C, Fonouni H, et al., Distinct effects of surgical denervation on hepatic perfusion, bowel ischemia, and oxidative stress in brain dead and living donor porcine models. Liver Transpl 2007; 13: 607-617. (Pubitemid 46605865)
30. Luntz SP, Unnebrink K, Seibert-Grafe M, et al., HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]. BMC Surg 2005; 5: 18.
31. Beck-Schimmer B, Breitenstein S, Urech S, et al., A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248: 909-918.
32. Lang JD Jr, Teng X, Chumley P, et al., Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007; 117: 2583-2591. (Pubitemid 47494359)
33. Aldrighetti L, Pulitanò C, Arru M, et al., Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 2006; 12: 941-949. (Pubitemid 43960370)
34. Kim YI, Chung HJ, Song KE, et al., Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver. Am J Surg 2006; 191: 72-76.
35. Bartels M, Biesalski HK, Engelhart K, et al., Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial. Clin Nutr 2004; 23: 1360-1370. (Pubitemid 39517629)
36. Samantaray S, Das A, Thakore NP, et al., Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 2009; 47: 134-142.
37. Sung JH, Cho EH, Kim MO, Koh PO,. Identification of proteins differentially expressed by melatonin treatment in cerebral ischemic injury - a proteomics approach. J Pineal Res 2009; 46: 300-306.
38. Diez ER, Prados LV, Carrion A, et al., A novel electrophysiologic effect of melatonin on ischemia/reperfusion-induced arrhythmias in isolated rat hearts. J Pineal Res 2009; 46: 155-160.
39. Li Z, Nickkholgh A, Yi X, et al., Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res 2009; 46: 365-372.
40. Brzezinski A,. Melatonin in humans. N Engl J Med 1997; 336: 186-195. (Pubitemid 27034965)
41. Reiter RJ, Tan DX,. What constitutes a physiological concentration of melatonin? J Pineal Res 2003; 34: 79-80. (Pubitemid 36140362)
42. Di WL, Kadva A, Johnston A, Silman R,. Variable bioavailability of oral melatonin. N Engl J Med 1997; 336: 1028-1029.
43. Demuro RL, Nafziger AN, Blask DE, et al., The absolute bioavailability of oral melatonin. J Clin Phamacol 2000; 40: 781-784.
44. Barchas J, Dacosta F, Spector S,. Acute pharmacology of melatonin. Nature 1967; 214: 19-920.
45. Jahnke G, Marr M, Muers C, et al., Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999; 50: 271-279. (Pubitemid 29407090)
46. Papavasilou PS, Cotzias GC, Duby SE, et al., Melatonin and Parkinsonism. JAMA 1972; 221: 88-89.
47. Mallo C, Zadan R, Galy G, et al., Pharmacokinetics of melatonin after intravenous infusion and bolus injection. Eur J Clin Pharmacol 1990; 38: 297-301. (Pubitemid 20137485)
48. Manda K, Ueno M, Anzai K,. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007; 42: 386-393. (Pubitemid 46581663)
49. Rosen J, Than NN, Koch D, et al., Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006; 41: 374-381. (Pubitemid 44498224)
50. Mistraletti G, Sabbatini G, Taverna M, et al., Pharmacokinetics of orally administered melatonin in critically ill patients. J Pineal Res 2010; 48: 142-147.
51. Hardeland R, Pandi-Perumal SR,. Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr Metab 2005; 2: 22.
52. Sulli A, Maestroni GJ, Villaggio B, et al., Melatonin serum levels in rheumatoid arthritis. Ann NY Acad Sci 2002; 966: 276-283. (Pubitemid 34729186)
53. Härtter S, Wang X, Weigmann H, et al., Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J Clin Psychopharmacol 2001; 21: 167-174. (Pubitemid 32221054)
54. Grözinger M, Härtter S, Wang X, et al., Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile. Arch Gen Psychiatry 2000; 57: 812-813. (Pubitemid 30650118)